These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8427821)

  • 1. Topical betamethasone-17-valerate inhibits heat-induced vasodilatation in man.
    Ahluwalia A; Flower RJ
    Br J Dermatol; 1993 Jan; 128(1):45-8. PubMed ID: 8427821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations into the mechanism of vasoconstrictor action of the topical steroid betamethasone-17-valerate in the rat.
    Ahluwalia A; Flower RJ
    Br J Pharmacol; 1993 Feb; 108(2):544-8. PubMed ID: 8448601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
    Bjerring P
    Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application.
    Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O
    S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of topical capsaicin on the local thermal control of skin blood flow in humans.
    Stephens DP; Charkoudian N; Benevento JM; Johnson JM; Saumet JL
    Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R894-901. PubMed ID: 11507006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To reheat, or to not reheat: that is the question: the efficacy of a local reheating protocol on mechanisms of cutaneous vasodilatation.
    Del Pozzi AT; Hodges GJ
    Microvasc Res; 2015 Jan; 97():47-54. PubMed ID: 25281012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
    Ryatt KS; Cotterill JA; Mehta A
    J Clin Hosp Pharm; 1983 Jun; 8(2):143-5. PubMed ID: 6875011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of a new topical preparation containing dextran sulphate and betamethasone 17-valerate.
    Passarella E; Milanino R
    Arzneimittelforschung; 1980; 30(4):647-51. PubMed ID: 6156688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten days of repeated local forearm heating does not affect cutaneous vascular function.
    Francisco MA; Brunt VE; Jensen KN; Lorenzo S; Minson CT
    J Appl Physiol (1985); 2017 Aug; 123(2):310-316. PubMed ID: 28473615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching.
    Meyer E; Smith EW; Haigh JM
    Br J Dermatol; 1992 Oct; 127(4):379-81. PubMed ID: 1419758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of sensory nerves to the onset threshold for cutaneous vasodilatation during gradual local skin heating of the forearm and leg.
    Hodges GJ; McGarr GW; Mallette MM; Del Pozzi AT; Cheung SS
    Microvasc Res; 2016 May; 105():1-6. PubMed ID: 26679388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical mometasone furoate and betamethasone-17-valerate decrease collagen synthesis to a similar extent in human skin in vivo.
    Koivukangas V; Karvonen J; Risteli J; Oikarinen A
    Br J Dermatol; 1995 Jan; 132(1):66-8. PubMed ID: 7756153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration.
    Kubota K; Lo ES; Huttinot G; Andersen PH; Maibach HI
    Br J Clin Pharmacol; 1994 Jan; 37(1):86-8. PubMed ID: 8148226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream.
    Magnus AD; Haigh JM; Kanfer I
    Dermatologica; 1980; 160(5):321-7. PubMed ID: 7364141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
    Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
    J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential vasodilatory responses to local heating in facial, glabrous and hairy skin.
    Metzler-Wilson K; Kellie LA; Tomc C; Simpson C; Sammons D; Wilson TE
    Clin Physiol Funct Imaging; 2012 Sep; 32(5):361-6. PubMed ID: 22856342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.